Company intelligence / Profile preview
InGeneron
Houston, Texas, United Statesingeneron.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company has reported positive long-term results for their cell therapy as of November 2023, and is conducting several clinical trials to validate their technology as a disease-modifying treatment for orthopedic conditions
- Therapeutic areas
- Rheumatology
- Modalities
- Cell-based therapiesregenerative cell therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on InGeneron.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InGeneron.